Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-May-24 5:52 PM View:  | Arvinas, Inc. (ARVN) | 29-May-24 | Grant | 5,899 | -- | -- | 72% 8.24K to 14.14K | |
| 17-Sep-21 4:27 PM View: | Sana Biotechnology, Inc. (SANA) | 16-Sep-21 | Market Sale (Planned) | 1,627 | $26.00 | $42,302.00 | (< 1%) 1.55M to 1.55M | 1% |
| 17-Sep-21 4:27 PM View: | Sana Biotechnology, Inc. (SANA) | 15-Sep-21 | Market Sale (Planned) | 58,373 | $26.07 | $1,521,750.00 | (4%) 1.61M to 1.55M | 1% |
| 19-Nov-20 8:20 PM View: | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 4,100 | -- | -- | (100%) 4.1K to 0 | |
| 16-Jun-20 6:09 PM View: | Myokardia, Inc. (MYOK) | 13-Jun-20 | Option Exercise | 2,300 | -- | -- | 100% 0 to 2.3K | |
| 07-Mar-18 6:11 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Mar-18 | Disposition | 149,577 | -- | -- | (100%) 149.58K to 0 | |
| 02-Feb-18 7:25 PM View: | Juno Therapeutics, Inc. (JUNO) | 31-Jan-18 | Grant | 29,135 | -- | -- | 24% 120.44K to 149.58K | |
| 20-Oct-17 8:24 PM View: | Juno Therapeutics, Inc. (JUNO) | 20-Oct-17 | Grant | 35,893 | -- | -- | 42% 84.55K to 120.44K | |
| 04-Oct-17 7:31 PM View: | Juno Therapeutics, Inc. (JUNO) | 02-Oct-17 | Market Sale (Planned) | 7,285 | $44.76 | $326,088.00 | (8%) 91.83K to 84.55K | (94%) |
| 17-Apr-17 7:58 PM View: | Juno Therapeutics, Inc. (JUNO) | 13-Apr-17 | Grant | 96,627 | -- | -- | 100% 0 to 96.63K | |
| 17-Apr-17 7:58 PM View: | Juno Therapeutics, Inc. (JUNO) | 13-Apr-17 | Payment of Exercise | 4,793 | $24.01 | $115,080.00 | (5%) 96.63K to 91.83K | (262%) |
| 23-Aug-16 5:52 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Aug-16 | Payment of Exercise | 392 | $66.00 | $25,872.00 | (4%) 9.53K to 9.14K | (138%) |
| 21-Jul-16 5:09 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 21-Jul-16 | Market Sale (Planned) | 649 | $52.68 | $34,189.30 | (6%) 10.18K to 9.53K | (198%) |
| 21-Jul-16 5:09 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Jul-16 | Payment of Exercise | 392 | $50.55 | $19,815.60 | (4%) 10.57K to 10.18K | (211%) |
| 21-Jun-16 4:01 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 20-Jun-16 | Market Sale (Planned) | 650 | $54.16 | $35,204.00 | (6%) 11.22K to 10.57K | (190%) |
| 21-Jun-16 4:01 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Jun-16 | Payment of Exercise | 392 | $54.99 | $21,556.10 | (3%) 11.61K to 11.22K | (186%) |
| 03-Jun-16 4:08 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Jun-16 | Grant | 4,500 | -- | -- | 63% 7.11K to 11.61K | |
| 26-May-16 5:18 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 24-May-16 | Market Sale (Planned) | 650 | $66.00 | $42,900.00 | (8%) 7.76K to 7.11K | (138%) |
| 23-May-16 7:14 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 21-May-16 | Payment of Exercise | 414 | $64.01 | $26,500.10 | (5%) 8.18K to 7.76K | (145%) |
| 23-May-16 7:14 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-May-16 | Payment of Exercise | 392 | $61.46 | $24,092.30 | (5%) 8.57K to 8.18K | (156%) |
| 21-Apr-16 4:32 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 20-Apr-16 | Market Sale (Planned) | 649 | $70.53 | $45,774.00 | (7%) 9.22K to 8.57K | (123%) |
| 21-Apr-16 4:32 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Apr-16 | Payment of Exercise | 392 | $69.86 | $27,385.10 | (4%) 9.61K to 9.22K | (125%) |
| 24-Mar-16 4:14 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 22-Mar-16 | Market Sale (Planned) | 650 | $61.45 | $39,942.50 | (6%) 10.26K to 9.61K | (156%) |
| 22-Mar-16 4:01 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Mar-16 | Payment of Exercise | 392 | $56.32 | $22,077.40 | (4%) 10.65K to 10.26K | (179%) |
| 23-Feb-16 5:48 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 22-Feb-16 | Market Sale (Planned) | 658 | $63.48 | $41,769.80 | (6%) 11.31K to 10.65K | (148%) |
| 23-Feb-16 5:48 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Feb-16 | Payment of Exercise | 384 | $63.27 | $24,295.70 | (3%) 11.69K to 11.31K | (148%) |
| 21-Jan-16 4:04 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 20-Jan-16 | Market Sale (Planned) | 585 | $72.83 | $42,605.60 | (5%) 12.78K to 12.19K | (116%) |
| 21-Jan-16 4:04 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Jan-16 | Payment of Exercise | 456 | $71.52 | $32,613.10 | (3%) 13.23K to 12.78K | (120%) |
| 24-Dec-15 1:01 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 22-Dec-15 | Market Sale (Planned) | 498 | $114.81 | $57,175.40 | (4%) 13.73K to 13.23K | (37%) |
| 22-Dec-15 4:01 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Dec-15 | Payment of Exercise | 544 | $109.87 | $59,769.30 | (4%) 14.27K to 13.73K | (43%) |
| 24-Nov-15 4:01 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 23-Nov-15 | Market Sale (Planned) | 498 | $95.88 | $47,748.20 | (3%) 14.27K to 13.78K | (64%) |
| 23-Nov-15 4:10 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Nov-15 | Payment of Exercise | 544 | $97.71 | $53,154.20 | (4%) 14.82K to 14.27K | (61%) |
| 21-Oct-15 5:02 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 20-Oct-15 | Market Sale (Planned) | 649 | $85.51 | $55,496.00 | (4%) 15.47K to 14.82K | (84%) |
| 21-Oct-15 5:02 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Oct-15 | Payment of Exercise | 392 | $88.94 | $34,864.50 | (2%) 15.86K to 15.47K | (77%) |
| 24-Sep-15 4:22 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 22-Sep-15 | Market Sale (Planned) | 498 | $109.51 | $54,536.00 | (3%) 16.36K to 15.86K | (43%) |
| 21-Sep-15 2:09 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Sep-15 | Payment of Exercise | 544 | $129.91 | $70,671.00 | (3%) 16.9K to 16.36K | (21%) |
| 21-Aug-15 7:32 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 20-Aug-15 | Option Exercise | 10,000 | $55.88 | $558,800.00 | 42% 23.92K to 33.92K | |
| 21-Aug-15 7:32 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 20-Aug-15 | Market Option Sale (Planned) | 10,000 | $111.18 | $1,111,760.00 | (29%) 33.92K to 23.92K | (41%) |
| 21-Aug-15 7:32 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 20-Aug-15 | Market Sale (Planned) | 7,020 | $111.18 | $780,454.00 | (29%) 23.92K to 16.9K | (41%) |
| 21-Aug-15 7:32 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Aug-15 | Payment of Exercise | 5,480 | $116.99 | $641,105.00 | (19%) 29.4K to 23.92K | (34%) |
| 27-May-15 5:00 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 21-May-15 | Grant | 4,400 | -- | -- | 18% 25.0K to 29.4K | |
| 21-Aug-14 6:47 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Aug-14 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K |